| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/26/2003 | EP1294753A2 A human homologue of the db4/ask1 protein, nucleic acids, and methods related to the same |
| 03/26/2003 | EP1294752A2 Angiogenesis-modulating compositions and uses |
| 03/26/2003 | EP1294751A1 Dermacentor variabilis gaba-gated chloride channels |
| 03/26/2003 | EP1294750A2 Acid-modified arabinogalactan protein composition |
| 03/26/2003 | EP1294749A2 Use of recombinant antigens to determine the immune status of an animal |
| 03/26/2003 | EP1294748A2 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 03/26/2003 | EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/26/2003 | EP1294744A2 Peptides that stimulate cell survival and axon regeneration |
| 03/26/2003 | EP1294743A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis |
| 03/26/2003 | EP1294738A2 Novel motor proteins and methods for their use |
| 03/26/2003 | EP1294472A1 Electrophoresis separation and treatment of samples |
| 03/26/2003 | EP1294409A2 Membrane-permeant peptide complexes for medical imaging |
| 03/26/2003 | EP1294406A2 Modulation of chromosome function by chromatin remodeling agents |
| 03/26/2003 | EP1294400A1 Vaccine against foot-and-mouth disease |
| 03/26/2003 | EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 03/26/2003 | EP1294386A1 Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof |
| 03/26/2003 | EP1294227A2 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 03/26/2003 | EP1165755A4 Banana and melon promoters for expression of transgenes in plants |
| 03/26/2003 | EP1150701A4 Homing pro-apoptotic conjugates and methods of using same |
| 03/26/2003 | EP1141269A4 Secreted proteins and uses thereof |
| 03/26/2003 | EP1112096B1 Collagenous tissue compositions |
| 03/26/2003 | EP1091948B1 Tubulin binding compounds (cobra) |
| 03/26/2003 | EP1064012A4 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding |
| 03/26/2003 | EP1012184A4 Derivatives of growth hormone and related proteins |
| 03/26/2003 | EP1005483A4 Methods and compositions for rapid furification of proteasomes and methods of use of components thereof |
| 03/26/2003 | EP0994898B1 Integrin binding peptide and use thereof |
| 03/26/2003 | EP0976331B1 Soybean protein hydrolysates, their production and use |
| 03/26/2003 | EP0956038B1 Morphogen peptide-induced regeneration of sense perceptory tissues |
| 03/26/2003 | EP0950063B1 Multiple branch peptide constructions |
| 03/26/2003 | EP0939809B1 Tie-2 receptor ligand (tie ligand-4) and its use |
| 03/26/2003 | EP0900383B1 Peptides having specific affinity to pacap type 1 receptors |
| 03/26/2003 | EP0835261B1 Ion channel |
| 03/26/2003 | EP0833658B1 Inhibin compositions and methods of enhancing production performance |
| 03/26/2003 | EP0831867B1 Collagen-based delivery matrix |
| 03/26/2003 | EP0759037B1 Antigen/antibody specificity exchanger |
| 03/26/2003 | EP0625159B1 Ikaros: a regulatory gene involved in t-cell differentiation |
| 03/26/2003 | EP0610436B9 Hepatitis-c virus testing |
| 03/26/2003 | EP0431128B1 Vector coding for self-assembled, defective, non-self-propagating viral particles |
| 03/26/2003 | EP0261224B2 Synthetic htlv-iii peptides, compositions and uses thereof |
| 03/26/2003 | CN1406284A Immunoassay and diagnostic reagent for malaria |
| 03/26/2003 | CN1406280A Progenitor cell preservation factors and related methods and products |
| 03/26/2003 | CN1406278A Expression of recombinant mature lysostaphin |
| 03/26/2003 | CN1406277A Recombinant attenuation of PRRSV |
| 03/26/2003 | CN1406276A Sericin-containing material, Process for producing the same and method of using the same |
| 03/26/2003 | CN1406249A Enhancing the circulating half-life of antibody-based fusion proteins |
| 03/26/2003 | CN1406247A Method of monomerizing human serum albumin polymers |
| 03/26/2003 | CN1406246A Method of producing human albumin involving heating step |
| 03/26/2003 | CN1406245A Method of eliminating human serum albumin polymers |
| 03/26/2003 | CN1406244A Compounds for detection of infection by chlamydophila abortus |
| 03/26/2003 | CN1406136A Novel antibody with specificity for colon cancer |
| 03/26/2003 | CN1406108A Method for lowering pollen fertility by using tapetal layer-specific zinc finger transcriptional factor gene |
| 03/26/2003 | CN1405311A Cnidarian cytotoxin gene and its expression and application |
| 03/26/2003 | CN1405310A Method for producing medicine using silkworm expressed numan epidermal growth factor |
| 03/26/2003 | CN1405309A Method for preparing medicine using silkworm expressed human beta interferon |
| 03/26/2003 | CN1405308A Method for producing medicine using silkworm expressed human alpha2b interferon |
| 03/26/2003 | CN1405298A Yeast recombinant strain and IFN alpha-2b interferon purifying method |
| 03/26/2003 | CN1405183A Serum albumin and granulocyte-macrophage colony stimulating factor fusion protein |
| 03/26/2003 | CN1405182A 血清白蛋白与粒细胞集落刺激因子的融合蛋白 Serum albumin and granulocyte colony-stimulating factor fusion protein |
| 03/26/2003 | CN1405181A Serum albumin and interferon fusion protein |
| 03/26/2003 | CN1405180A Chemotactic factor beta-8 short type |
| 03/26/2003 | CN1405174A Housefly phylaxin gene, and its cloning method and recombinant application |
| 03/26/2003 | CN1405150A Protein modifier, preparation method and use thereof |
| 03/26/2003 | CN1103812C Human beta-2 integrin alpha subunit |
| 03/26/2003 | CN1103782C Mono-pegylated MGDF polypeptide |
| 03/26/2003 | CN1103781C Abundant extracellular product and methods for production and use of same |
| 03/26/2003 | CN1103602C Process for preparing pharmaceutical formulation containing insulin analog |
| 03/26/2003 | CA2423858A1 Novel proteins, genes encoding them and method of using the same |
| 03/25/2003 | USRE38046 (delayed type sensitivity) DTH-Effector cells are printed with carbohydrate antigens; antitumor |
| 03/25/2003 | US6538182 Genetic modification of plants to control age-related or environmental stress-induced senescence; use in extending shelf-life and slowing spoilage of plant cuttings, flowers, seeds, fruits, vegatables, or leaves |
| 03/25/2003 | US6538176 In the genetic manipulation of plants, particularly to modulating DNA metabolism in transformed plants and plant cells |
| 03/25/2003 | US6538175 Method for selecting disease resistant plants by marker assisted selection techniques; use in identifying quantitative trait loci associated with nematode resistance in plants |
| 03/25/2003 | US6538127 Synthetic HIV-2 envelope genes containing modifications that lead to optimized expression in bacteria |
| 03/25/2003 | US6538126 Polynucleotides of given sequence derived from CDNA |
| 03/25/2003 | US6538125 Insertion sequence element derived from Ralstonia solanacearum |
| 03/25/2003 | US6538123 Vaccine composition for preventing or treating hepatitis C |
| 03/25/2003 | US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 03/25/2003 | US6538120 Genomic sequence of the human μ-opioid receptor gene and the variants, polymorphisms and mutations thereof |
| 03/25/2003 | US6538119 Nucleotide sequences for use in the classification, diagnosis, prevention, imaging and treatment of mammary gland defects |
| 03/25/2003 | US6538118 Expression of lipoproteins |
| 03/25/2003 | US6538113 Methods of obtaining antibody directed against prothrombin fragments F2/F1+2 |
| 03/25/2003 | US6538111 Monoclonal, humanized antibodies; hybridomas; transformants; use in diagnosis and treatment of chronic bronchial asthma |
| 03/25/2003 | US6538109 Polynucleotide compositions encoding broad spectrum delta-endotoxins |
| 03/25/2003 | US6538108 Compositions and methods relating to DNA mismatch repair genes |
| 03/25/2003 | US6538107 G protein coupled receptor protein production, and use thereof |
| 03/25/2003 | US6538106 Compositions and methods for treating infections using analogues of indolicidin |
| 03/25/2003 | US6538104 Stabilization of cardiac troponin I subunits and complexes |
| 03/25/2003 | US6538103 Anti-angiogenic agents; kringle 1; use treatment of cancer, diabetic retinopathy, rheumatoid arthritis, psoriasis, arteriosclerotic plaque formation |
| 03/25/2003 | US6537972 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/25/2003 | US6537967 Treating human immunodeficiency virus infections |
| 03/25/2003 | US6537966 Follistatin-3 |
| 03/25/2003 | US6537965 Novel parathyroid hormone (PTH) peptide derivatives. In particular, the invention relates to PTH PTH-2 receptor agonist or antagonist properties to the derivatives. |
| 03/25/2003 | US6537815 Method of altering the expression of csrB to modify the properties of a cell |
| 03/25/2003 | US6537810 Methods for regulating T cell subsets by modulating transcription factor activity |
| 03/25/2003 | US6537804 Expression vector comprising a DNA sequence that expresses a peptide of given amino acid sequence which includes tyrosine; use in diagnosis and treatment of leukemia |
| 03/25/2003 | US6537803 Produced by a recombinant expression vector in a cell; use in pharmacology and drug screening |
| 03/25/2003 | US6537794 Chemokine |
| 03/25/2003 | US6537786 Genes encoding exopolysaccharide production |
| 03/25/2003 | US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 03/25/2003 | US6537781 Methods and compositions concerning canine interleukin 5 |
| 03/25/2003 | US6537778 Eukaryotic mechanosensory transduction channel |